| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701966 | Journal of Thoracic Oncology | 2017 | 28 Pages |
Abstract
Our data suggest that CYP24A1 has oncogenic properties mediated by increasing RAS signaling, targeting of which may provide an alternate strategy to treat a subset of lung AC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hiroe PhD, Zhuwen MS, Guoan MD, PhD, Paramita PhD, Jules MD, Zhuo PhD, Lili PhD, David PhD, Dipankar PhD, Nithya M.B.B.S.,